Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01593254
Title Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib (DASCERN)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications

chronic myeloid leukemia

Therapies

Imatinib

Dasatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT

Additional content available in CKB BOOST